CA2363565A1 - Polypeptides basb059 provenant de neisseria meningitidis - Google Patents

Polypeptides basb059 provenant de neisseria meningitidis Download PDF

Info

Publication number
CA2363565A1
CA2363565A1 CA002363565A CA2363565A CA2363565A1 CA 2363565 A1 CA2363565 A1 CA 2363565A1 CA 002363565 A CA002363565 A CA 002363565A CA 2363565 A CA2363565 A CA 2363565A CA 2363565 A1 CA2363565 A1 CA 2363565A1
Authority
CA
Canada
Prior art keywords
polypeptide
polynucleotide
seq
sequence
basb059
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002363565A
Other languages
English (en)
Inventor
Joelle Thonnard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2363565A1 publication Critical patent/CA2363565A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Abstract

L'invention concerne des polypeptides BASB059 et des polynucléotides codant pour les polypeptides BASB059 ainsi que des procédés de fabrication de ces polypeptides par des techniques recombinantes. L'invention concerne aussi des utilisations diagnostiques, prophylactiques et thérapeutiques.
CA002363565A 1999-01-29 2000-01-25 Polypeptides basb059 provenant de neisseria meningitidis Abandoned CA2363565A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9902070.3 1999-01-29
GBGB9902070.3A GB9902070D0 (en) 1999-01-29 1999-01-29 Novel compounds
PCT/EP2000/000561 WO2000044904A1 (fr) 1999-01-29 2000-01-25 Polypeptides basb059 provenant de neisseria meningitidis

Publications (1)

Publication Number Publication Date
CA2363565A1 true CA2363565A1 (fr) 2000-08-03

Family

ID=10846791

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002363565A Abandoned CA2363565A1 (fr) 1999-01-29 2000-01-25 Polypeptides basb059 provenant de neisseria meningitidis

Country Status (8)

Country Link
EP (1) EP1151107A1 (fr)
JP (1) JP2002537764A (fr)
CN (1) CN1415013A (fr)
AU (1) AU3276800A (fr)
CA (1) CA2363565A1 (fr)
GB (1) GB9902070D0 (fr)
HK (1) HK1042924A1 (fr)
WO (1) WO2000044904A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013214105A1 (en) 2012-02-02 2014-07-24 Novartis Ag Promoters for increased protein expression in meningococcus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8921227D0 (en) * 1989-09-20 1989-11-08 Wellcome Found Antibodies and proteins
FR2751000B1 (fr) * 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
FR2785293B1 (fr) * 1998-10-30 2002-07-05 Pasteur Merieux Serums Vacc Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria

Also Published As

Publication number Publication date
GB9902070D0 (en) 1999-03-24
EP1151107A1 (fr) 2001-11-07
CN1415013A (zh) 2003-04-30
HK1042924A1 (zh) 2002-08-30
JP2002537764A (ja) 2002-11-12
AU3276800A (en) 2000-08-18
WO2000044904A1 (fr) 2000-08-03

Similar Documents

Publication Publication Date Title
US8580279B2 (en) Compounds
US20050272091A1 (en) Polynucleotides and polypeptides BASB033 from Neisseria meningitidis and their uses
CA2360084A1 (fr) Composes immunogeniques
US20100203057A1 (en) Novel compounds
WO2000042192A1 (fr) POLYPEPTIDES BASB052 DE $i(NEISSERIA MENINGITIDIS)
CA2360658A1 (fr) Polypeptides antigeniques de neisseria meningitidis, polynucleotides correspondants et anticorps protecteurs
US20080057067A1 (en) Polypeptides and Polynucleotides "BASB040" From Neisseria Meningitidis and Vaccine Comprising Said Polypeptides and Polynucleotides
US7521549B2 (en) Compounds
EP1105493A1 (fr) Les basb024, proteines de la membrane exterieure du neisseria meningitidis
US20050075485A1 (en) Neisseria meningitidis antigen
EP1149165A1 (fr) Polynucleotides et polypeptides basb055 de neisseria meningitis et leurs utilisations
CA2363565A1 (fr) Polypeptides basb059 provenant de neisseria meningitidis
CA2359799A1 (fr) Antigene contre le serogroupe b de neisseria meningitidis

Legal Events

Date Code Title Description
FZDE Dead